Dapagliflozin for heart failure according to body mass index: the DELIVER trial.
Adamson C, Kondo T, Jhund PS, de Boer RA, Cabrera Honorio JW, Claggett B, Desai AS, Alcocer Gamba MA, Al Habeeb W, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Langkilde AM, Lindholm D, Bachus E, Litwin SE, Martinez F, Petersson M, Shah SJ, Vaduganathan M, Nguyen Vinh P, Wilderäng U, Solomon SD, McMurray JJV.
Adamson C, et al.
Eur Heart J. 2022 Nov 1;43(41):4406-4417. doi: 10.1093/eurheartj/ehac481.
Eur Heart J. 2022.
PMID: 36029309
Free PMC article.